AMGNAmgen
Pharma & Healthcare · US · Amgen Inc.
4 of 6 ratios computed · receipts verified server-side
Idiot Index
90
out of 100 · 4/6 ratios · FY 2023
The full receipt
Latest published value for each ratio, with the sector median for context and year-over-year change where the prior year is available.
- Markup →
How much revenue per dollar of cost.
4.0253× revenue / costverified$1 of cost becomes $4.03 of revenueSector median: 3.1882Median range for extraction in sectorFY 2023v1.0.0 - Operational Markup →
Revenue per dollar of cost + operating expenses. The multiplier after legitimate operations.
1.4165× revenue / (cost + opex)verified$1 of cost+opex becomes $1.42 of revenueSector median: 1.2871Top 23% for extraction in sectorFY 2023v1.0.0 - Labor Share →
How much of every revenue dollar reaches workers.
Not computed: missing input.Needed but not in this company's XBRL filings: Total Employee Compensation.What this company did disclose: Stock Buybacks, Cost of Goods Sold, Dividends Paid, Net Income, Operating Expenses, R&D Expense, Revenue - Executive Extraction →
How many times a CEO out-earns the median employee.
Not computed: missing inputs.Needed but not in this company's XBRL filings: CEO Total Compensation, Median Employee Compensation.What this company did disclose: Stock Buybacks, Cost of Goods Sold, Dividends Paid, Net Income, Operating Expenses, R&D Expense, Revenue - Shareholder Extraction →
Dollars sent to shareholders for every dollar invested in R&D.
1.8651× buybacks+dividends / R&Dverified$1.87 to shareholders for every $1 in R&DSector median: 0.7492Top 21% for extraction in sectorFY 2023v1.0.0 - Capital Extraction →
How much of net profit goes to shareholders rather than back into the business.
1.5252× buybacks+dividends / net incomeverified153% of net profit returned to shareholders — funded beyond current-year earningsSector median: 0.5294Top 3% for extraction in sectorFY 2023v1.0.0